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Abstract
Background:  Chinese medicine decoctions such as Yinchenhao Tang (YCHT),  Xiayuxue Tang
(XYXT), Huangqi Tang (HQT), Yiguan Jian (YGJ) and Xiaochaihu Tang (XCHT)) were used to treat liver
cirrhosis. The present study evaluates the effects of these decoctions on fibrosis in rats induced by
dimethylnitrosamine (DMN).
Methods: DMN solution (0.5%) was injected to rats for three consecutive days per week for four
weeks. At the beginning of week 3, rats were randomly divided into 4-week DMN control group,
YCHT, XYXT, HQT, YGJ, XCHT and vehicle groups. Each group was orally administered with specific
decoctions daily for two weeks. Rats in the vehicle group were orally administered with only water.
Results: Liver fibrosis and cirrhosis were observed in weeks 2 and 4 in DMN-intoxicated rats.
Compared with normal rats, alanine transaminase (ALT), aspartate transaminase (AST), alkaline
phosphatase (ALP) activities and level of total bilirubin acid (TBA) in serum and content of
Hydroxyproline (Hyp) in liver tissue of model group rats rose significantly. However, the albumin
(Alb) level in serum decreased significantly. Compared with the 4-week DMN group, the
pathological conditions and functions of the liver in the YCHT group improved significantly, and the
content of Hyp decreased remarkably: only one rat in this group developed liver cirrhosis and the
ratio of cirrhosis was only 8.3%. On the other hand, the other decoctions did not show remarkable
effects. YCHT inhibited α-SMA activation, including its gene expression into mRNA and protein.
Conclusion: Among the five Chinese medicine decoctions, YCHT exerted the most significant
therapeutic effects on DMN-induced cirrhosis/fibrosis in rats.
Background
Liver fibrosis occurs as a result of a variety of pathological
factors, including viral hepatitis (especially hepatitis B
and C), alcohol and drug abuse, metabolic diseases due to
overload of iron or copper, autoimmunity against hepato-
cytes or bile duct epithelium, and congenital abnormali-
Published: 31 January 2008
Chinese Medicine 2008, 3:1 doi:10.1186/1749-8546-3-1
Received: 16 May 2007
Accepted: 31 January 2008
This article is available from: http://www.cmjournal.org/content/3/1/1
© 2008 Liu et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Chinese Medicine 2008, 3:1 http://www.cmjournal.org/content/3/1/1
Page 2 of 9
(page number not for citation purposes)
ties [1]. Liver fibrosis, cirrhosis in particular, is associated
with significant morbidity and mortality. As liver fibrosis
may not manifest itself clinically until an advanced (i.e.
cirrhotic) stage, the capability of reversing the fibrosis is
highly desirable for developing therapeutic approaches
[2]. At present, there is no standard treatment for liver
fibrosis. Experimental studies indicated that the progres-
sion of liver fibrosis can be prevented in rodents [3],
although the efficacy of most of the preventive treatments
has not been established in humans. Therefore, it is
imperative to develop anti-fibrotic strategies to treat liver
fibrosis and cirrhosis.
Chinese medicine has been widely used for treating
chronic liver hepatitis and liver cirrhosis. Chinese medi-
cine treatment improved clinical symptoms, liver func-
tion and quality of life for patients, inhibited liver
inflammation and fibrous tissue proliferation, and
reversed liver fibrosis. According to Chinese medicine the-
ories, liver cirrhosis is caused by internal damp (Shi) heat
(Re), blood (Xue) stasis, and both Qi and Yin asthenia.
Thus, the main Chinese medicine approach to liver cir-
rhosis is to eliminate heat, dispel dampness, activate
blood, promote Qi and cultivate Yin [4-6]. In this study,
five classical decoctions, namely Yinchenhao Tang (YCHT),
Xiayuxue Tang (XYXT), Huangqi Tang (HQT), Yiguan Jian
(YGJ) and Xiaochaihu Tang (XCHT) were used to treat liver
cirrhosis induced by DMN (dimethylntrosamine) in rats.
First described in Shanghan Lun in 200 AD, YCHT consists
of three medicinal herbs: Herba Artemisiae Scopariae
(Yinchenhao), Fructus Gardeniae (Zhizi), and Radix et Rhi-
zoma Rhei (Dahuang), at a weight ratio of 18:10:6 respec-
tively. YCHT has been recognized by some practitioners
and researchers for its beneficial effects in treating liver
diseases [7]. YCHT was shown to ameliorate hepatitis [8]
and liver fibrosis in various animal fibrotic models [9-12].
XYXT was first described in Jinkui Yaolue in the East Han
Dynasty. It consists of three herbs: Radix et Rhizoma Rhei
(Dahuang), Semen Persicae (Taoren), and Eupolyphaga Seu
Steleophaga  (Tubiechong), at a weight ratio of 10:10:6
respectively.  XYXT  significantly inhibited liver fibrosis
induced by porcine serum [13] and CCl4 in rats. HQT was
first described in Hejiju Fang. It consists of three medicinal
herbs: Radix Astragali (Huangqi), Radix et Rhizoma Glycyr-
rhizae (Gancao), and Fructus Jujubae (Dazao), at a weight
ratio of 6:1:1. HQT and its components inhibited bile-
duct-ligation (BDL)-induced cholestatic cirrhosis [14].
YGJ was first described in Liuzhou Yihua and consists of six
herbs:  Radix Glehniae (Beishashen),  Radix Ophiopogonis
(Maimendong), Radix Angelicae Sinensis (Danggui), Radix
Rehmanniae (Shengdihuang), Fructus Lycii (Gouqizi), and
Fructus Toosendan (Chuanlianzi). It was found to inhibit
CCl4-induced cirrhosis [15]. XCHT  consists of seven
herbs: Radix Bupleuri (Chaihu), Radix Scutellariae (Huang-
qin),Radix Ginseng (Renshen),Rhizoma Pinelliae
(Banxia),Radix et Rhizoma Glycyrrhizae (Gancao),Rhizoma
Zingiberis Recens (Shengjiang),Fructus Jujubae (Dazao). It
was first described in Shanghan Lun and has been widely
used to treat chronic hepatitis in Japan since the 1970s. Its
anti-fibrosis action has been reported [16].
This study aims to (1) determine which of these five
decoctions is most effective to treat DMN-induced liver




DMN was purchased from Sigma. Hydroxyproline (Hyp)
standard was purchased from Nakateitesuku Corporation
(Japan). Liver function test kit was purchased from Nan-
jing Jiancheng Biotech Company (China). XCHT (TJ-9)
was purchased from Tumura Corporation (Japan). Herb
constituents of YCHT,  XYXT,  HQT  and  YGJ  were pur-
chased from Shanghai Huayu Chinese Herbs Co Ltd
(China). The herbs were accredited by a pharmacognosist
according to standard protocols, prepared by Shuguang
Hospital, and then stored at -20°C.
Animal models of liver fibrosis
Eighty-eight male Wister rats of weight 180–200 g were
kept in an air-conditioned room at 25°C with a 12 hour
dark/light cycle and unlimited access to food and water.
They were randomly divided into two groups: (1) control
(n = 10) and (2) DMN (n = 78). DMN (10 mg/kg body
weight) was administered intraperitoneally to DMN rats
for three consecutive days each week for four weeks [2];
normal saline was given to control rats. At the end of week
2, three control rats and six DMN rats were sacrificed for
observation. The remaining DMN rats (n = 72) were ran-
domly divided into six groups: DMN+ water, YCHT,
XYXT, HQT, YGJ and XCHT (n = 12). At the end of week
4, all rats were anesthetized with 40 mg/kg body weight
sodium pentobarbital. Blood was collected from interior
vena cava. The livers and spleens were immediately
removed, washed with ice-cold saline, dried by filter
paper, and weighed in the wet state.
Liver function tests
Serum was collected from blood by centrifugation at 1300
× g at 4°C and stored at -80°C for liver function tests.
Serum activities of alanine transaminase (ALT), aspartate
transaminase (AST), alkaline phosphatase (ALP), content
of albumin (Alb) and total bilirubin (TBIL) were tested.
Total bile acid (TBA) was measured by a clinical labora-
tory of Shuguang Hospital.Chinese Medicine 2008, 3:1 http://www.cmjournal.org/content/3/1/1
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Histology examination
Liver tissues were taken from the right lobe of the liver of
each rat, and fixed in 4% buffered paraformaldehyde,
dehydrated in a graded alcohol series. Following xylene
treatment, specimens were embedded in paraffin blocks,
cut into 5 μm-thick sections and placed on glass slides.
The sections were stained with hematoxylin-eosin and Sir-
ius red respectively. Fibrosis was graded according to the
method by Scheuer [17] as follows: grade 0: normal liver;
grade 1: an increase of collagen without the formation of
septa (small satellite expansion of the portal fields); grade
2: formation of incomplete septa not interconnecting
with each other, from the portal tract to the central vein;
grade 3: complete but thin septa interconnecting with
each other, which divide the parenchyma into separate
fragments; and grade 4: complete cirrhosis, similar to
grade 3 with thicker septa. The pathological examination
was performed by three pathologists who were blinded to
the rats' treatment assignment. Fibrosis scores were given
after the pathologists had thoroughly examined three dif-
ferent areas of the tissue slide for each rat.
Hepatic hydroxyproline content
Liver tissue (100 mg) was prepared for hydroxyproline
(Hyp) determination according to a modification of
method by Jamall et al. [18]. The Hyp content of the liver
as an indirect measure of tissue collagen content was
expressed as microgram per gram of wet weight (μg/g).
Expression and immunochemistry of α-SMA
Total RNA was extracted from 50 mg of liver tissue using
Trizol reagent (Invitrogen, USA). Synthesis of cDNA was
performed using 4 μg of total RNA per sample with ran-
dom primers and reagents contained in the RevertAid First
Strand cDNA synthesis kit (Fermentas, Lithuania). Two
microliters (2 μl) of each sample was used for real-time
PCR in a Rotor-Gene 2000 system (Australia). Relative
quantitation was calculated using delta cycle threshold
(CT) relative quantitation. Sequences and accession
number of primers used for alpha smooth muscle actin
(α-SMA) are: 5'-CGAGAGGACGTTGTTAGCATAGAG-3'
(forward) and 5'-GGGCATCCACGAAACCA-3' (reverse)
(GenBank accession number: BI282702; product length:
85 bp). Sequences and accession number of primers used
for 18S rRNA are: 5'-GTAACCCGTTGAACCCCATT-3'
(forward) and 5'-CCATCCAATCGGTAGTAGCG-3'
(reverse) (GenBank accession number: X00117; product
length: 151 bp).
Liver samples were prepared with Radio immunoprecipi-
tation assay (RIPA) lysis buffer containing protease inhib-
itors at 4°C. After quantification, the proteins (50 μg/
lane) were separated by polyacrylamide gel electrophore-
sis and transferred to Immobilon-P membranes which
were then blocked and exposed to α-SMA (Chemicon,
CBL171, 1:100, USA). The antigen was demonstrated by
enhanced chemiluminescence (Pierce, USA) for one
minute, followed by exposure to Kodak film (Kodak,
USA).
After deparaffinization and dehydration, microwave anti-
gen retrieval was performed for five minutes prior to per-
oxidase quenching with 3% H2O2 in PBS for 15 minutes.
Subsequently, the sections were preblocked with 5%
bovine serum albumin for 30 minutes. Slides were incu-
bated with anti-α-SMA (Sigma, A2547, 1:400, USA) anti-
body overnight at 4°C and with biotinylated secondary
antibodies for 45 minutes respectively. They were then
developed with diaminobenzidine (DAB) for 3 minutes
and finally counterstained with hematoxylin.
Statistical analysis
All results were expressed as mean and standard deviation
(SD). Measurement data were analyzed using a one-way
analysis of variances (ANOVA, SPSS 11.0). Rank data were
analyzed with ridit. The result of P < 0.05 was considered
to be statistically significant.
Results
Effects on survival and liver/spleen weight ratio
During drug intervention process, two rats died in the
DMN + XCHT group. Animal body and liver weights were
monitored during the formation of liver fibrosis (Table
1). Body weights of the rats from the 2-week DMN group
and 4-week DMN + water group were significantly lower
than those of the control group during the same period (P
< 0.01). Livers of the control rats were smooth, ruddy, and
soft, while those of the 2-week DMN rats were slightly big-
ger, accompanied by hyperemia and edema. In the DMN
+ water rats, livers were much smaller and more rigid.
Liver/body weight ratio of the DMN + water group was
significantly lower than that of the control group (P <
0.01); spleen/body weight ratio of the DMN + water
group significantly increased (P < 0.01). The liver/body
weight ratio of the YCHT group was higher than that of
the DMN + water group without significant difference.
Spleen weight of the YGJ group was significantly lower
than that of the 4-week DMN control group (P < 0.05).
No significant improvements were found in the other
groups.
Effects on hepatic histopathological changes
Livers in the control group showed normal lobular archi-
tecture with central vein and radiating hepatic cords (Fig-
ure 1a). After two weeks of DMN-intoxication, massive
hepatocyte necrosis, intense neutrophilic infiltration,
mild bile duct hyperplasia and initiation of fibrosis were
found (Figure 1a). There was diffuse centrilobular conges-
tion with marked dilatation of central veins. Extensive
necrosis and hemorrhage were prominent at this earlyChinese Medicine 2008, 3:1 http://www.cmjournal.org/content/3/1/1
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stage. In the DMN + water group, the liver sections
revealed collagen deposition, marked cirrhosis, collagen
fiber deposition, severe centrilobular necrosis, focal fatty
changes, bile duct proliferation, bridging necrosis and
apoptosis, and fibrosis surrounding the central veins (Fig-
ure 1a). In the DMN + YCHT group, marked reduction of
the thickening of the collagen bundles was seen. In the
DMN + XYXT/HQT/YGJ/XCHT groups, changes in hepa-
tocyte necrosis and bile duct hyperplasia were shown (Fig-
ure 1a).
Effects on liver collagen deposition
Quantitative assessment of liver fibrosis was performed
with morphometry on sections processed with 0.1% Sir-
ius red which specifically stains collagen. Collagen was
scarcely observed except around the small central venous
walls in normal liver (Figure 1b). In the 2-week DMN rats,
collagen was seen to stretch from portal area to lobular,
and incomplete septa were also observed (Figure 1b). In
the DMN + water rats, livers showed marked distortion in
architecture, including portal and lobular bridging fibro-
sis, cirrhotic nodule formation, and thickened reticulum
fibers joining central areas. Normal structure disappeared,
while pseudolobules formed (Figure 1b) with 75% rats
with cirrhosis. Compared with the DMN + water group,
fibrosis scores of livers in YCHT  group significantly
decreased (P < 0.05). Only one rat developed typical cir-
rhosis; the rate of cirrhosis was 8.3%. Ridit analysis
showed that the DMN + YCHT rats were significant differ-
ent from the DMN + water rats (P < 0.05). Other interven-
tion groups were not significant different (Figure 1 and
Table 2).
Effects on hepatic hydroxyproline content
Changes in Hyp content in the liver are considered an
index for collagen metabolism and provide valuable
information about the biochemical and pathological
states of liver fibrosis. Liver collagen content, expressed as
microgram (μg) of Hyp/gram (g) of liver tissue, is shown
in Table 2. The Hyp content in the DMN rats was approx-
imately 161% of that of the control group (P < 0.01) at the
end of week 2, suggesting abundant accumulation of col-
lagen in the livers of DMN rats. The highest increase,
which was about 3.6-fold compared with the control (P <
0.01), was observed at the end of week 4 in the DMN rats
+ water group. It was consistent with the observation of
marked cirrhosis and accumulation of collagen bundles in
the liver by histopathological examination. There was a
significant decrease (P < 0.05) in liver Hyp content (about
41% in the DMN + water rats) in the YCHT rats, suggest-
ing that YCHT ameliorated hepatic collagen deposition in
DMN-induced liver injury. Hyp content in the DMN +
HQT/XYXT rat livers was slightly reduced without signifi-
cant difference. Hyp content in DMN + XCHT/YGJ rats
was not changed.
Effects on liver function
Liver function parameters deteriorated over time in rats
subjected to DMN (Table 1). In DMN rats, ALT, AST, ALP,
TBIL and TBA levels were significantly higher after two
and four weeks compared with the control rats (P < 0.01),
indicating hepatic injury. ALT, AST, ALP, TBIL and TBA
levels also increased markedly in the cirrhotic DMN +
water rats. Oral administrations of YCHT  reduced the
DMN-induced increase in ALT, AST, ALP activities as well
as TBIL and TBA content (P < 0.01). These decreased bio-
chemical parameters in the DMN + water rats indicated
Table 1: Effects of five Chinese medicine decoctions on body weight, liver weight, spleen weight, liver/body, spleen/weight in DMN 
induced liver fibrosis of rats
Group Group size (n) Body weight(g) Liver weight (g) Spleen weight (g) Liver/body (%) Spleen/body (‰)
2-week control 3 226.0 (2.64)  7.80 (0.26) 0.66 (0.07)   3.45 (0.12)  2.90 (0.28)  
2-week DMN 6 175.8 (6.11) 7.02 (0.32)  1.02 (0.12)   3.99 (0.09)   5.80 (0.58) 
4-week control 7 287.0 (8.98)   10.03 (0.49)   0.76 (0.05)   3.49 (0.08)   2.64 (0.17)  
DMN + water 12 204.2 (20.22) 5.69 (1.78) 1.43 (0. 22) 2.73 (0.61) 7.27 (0.35)
DMN + YCHT 12 197.27 (22.10) 5.91 (1.95) 1.49 (0.25) 2.93 (0.74) 7.54 (0.68)
DMN + XYXT 12 208.33 (15.11) 5.22 (1.42) 1.60 (0.21) 2.48 (0.54) 7.67 (0.66)
DMN + HQT 12 212.00 (20.20) 5.52 (1.70) 1.57 (0.20) 2.58 (0.72) 7.44 (0.87)
DMN + YGJ 12 193.17 (24.41) 4.50 (1.57) 1.29 (0.21)  2.28 (0.59) 6.65 (0.67)
DMN + XCHT 10 216.70 (17.08) 5.22 (1.16) 1.55 (0.15) 2.40 (0.42) 7.17 (0.72)
 P < 0.05   P < 0.01 (vs DMN+ water)






Results are expressed as mean (SD).Chinese Medicine 2008, 3:1 http://www.cmjournal.org/content/3/1/1
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that YCHT ameliorated hepatic injury in the DMN rats.
Serum Alb content in the 2-week and 4-week DMN rats
was significantly lower than that in the control rats. YCHT
could elevate Alb content, but there was no significant dif-
ference compared with the DMN + water group (Table 3).
Effects of YCHT on the gene expression of α-SMA into 
mRNA and protein
In liver function test, histopatholgical observation and
hepatic Hyp content detection, YCHT showed a compre-
hensive inhibitory effect on DMN-induced liver fibrosis.
We went on to detect the anti-fibrotic function of YCHT
using molecular biology techniques.
Levels of α-SMA mRNA increased dramatically in the
DMN rats at week 2 (P < 0.01) (Figure 2a). They also
increased remarkably in the DMN + water group (P <
0.01). In the DMN + YCHT group, α-SMA mRNA expres-
sion decreased remarkably (P < 0.05) compared with the
DMN + water group. The result was also confirmed by
immunoblotting (Figure 2b).
In the control rats, α-SMA-positive hepatic stellate cells
(HSCs) were weakly stained and were only detected in
vascular structures (Figure 2c). Along with DMN-intoxica-
tion, the number of α-SMA-positive HSCs increased grad-
ually and reached peak at week 4 in cirrhotic livers (Figure
2c). In the DMN + YCHT group, number of α-SMA-posi-
tive HSCs was significantly reduced (Figure 2c).
Discussion
DMN-induced liver fibrosis in rats is a reproducible
model for studying the pathogenesis of liver fibrosis and
cirrhosis [19,20]. DMN-intoxication for four weeks pro-
duced centrilobular necrosis and fully-developed cirrhosis
in rats. The approximately four-fold increase of total liver
collagen observed in the present study is consistent with
the previous investigations on DMN-induced liver fibrosis
Effects of the five Chinese medicine decoctions on histological changes of liver Figure 1
Effects of the five Chinese medicine decoctions on histological changes of liver. (a) Hematoxylin - eosin (H&E) ×200. (A) Con-
trol rats (B) 2-week DMN fibrotic rats (C) DMN + water cirrhotic rats (D) DMN + YCHT rats (E) DMN + XYXT rats (F) DMN 
+ HQT rats (G) DMN + YGJ rats (H) DMN + XCHT rats. (b) Sirius red stain ×100. (A) Collagen was scarcely observed. (B) Col-
lagen was stretched from portal to lobular area. (C) Portal and lobular bridging fibrosis, and cirrhotic nodule formation were 
observed. (D) Fibrosis significantly decreased. (E), (F), (G) and (H) Changes in collagen deposition were observed.
a 
A B  D  C
B  A C
H  E 
D 
G F 
H  G E  F 
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in rats [21-24]. Two weeks of DMN-intoxication produced
diffuse centrilobular congestion with marked dilatation of
central veins. Extensive necrosis and hemorrhage were
prominent at this early stage; all rats developed liver fibro-
sis of grades 2–3. Liver Hyp content significantly increased
1.61-fold as compared with the normal rats. Notable
abnormality in liver function was also observed. In the
DMN + water group, liver damage significantly increased;
liver weight notably reduced and splenomegaly was
observed. Liver structure became disordered seriously
with rapid progress of fibrosis [25-27]. Hyp content in
liver tissue of the DMN + water group, which increased
3.68-fold, was much higher than that of the control
group. Seventy-five per cent (75%) of the DMN + water
group have developed cirrhosis. This study related to the
common symptoms of liver cirrhosis as well as its patho-
genesis in traditional Chinese medicine. Five decoctions
were chosen to prevent the rapid formation phase of liver
cirrhosis from fibrosis. This study revealed different effica-
cies of the five decoctions. The results showed that YCHT
had some specific therapeutic effects on pathological
changes in the liver. Liver weight reduction was stopped
and liver function was improved; serum activities of ALT,
AST and ALP were restrained at basic level for the 2-week
DMN rats; serum TBIL content was lowered for 2-week
DMN rats. Liver cell degeneration, necrosis, inflammation
Table 3: Effects of five Chinese medicine decoctions on serum activities of AST, ALT and ALP and serum content of TBA and TBIL in 
DMN-induced liver fibrosis of rats
Group ALT(U/L) AST(U/L) ALP (K/100 ml) TBA(μmol/L) TBIL (g/L) Alb (g/L)
Control 20.13 (3.10)   28.03 (4.33)   33.73 (4.95)   19.30 (6.03)   11.5 (0.93)   40.89 (2.23)  
2 week DMN 40.62 (4.96)   42.08 (2.35)   56.85 (9.80)   23.5 (8.06)   20.0 (6.52)   35.06 (2.27)  
DMN + water 70.30 (6.38) 81.08 (3.18) 97.67 (3.58) 56.8 (9.45) 24.1 (7.71) 26.38 (4.11)
DMN + YCHT 39.34 (5.87)   45.39 (5.16)   77.20 (5.28)   38.1 (10.08)   16.7 (4.68)  27.06 (4.16)
DMN + XYXT 60.26 (6.70)   70.89 (5.72) 83.55 (13.26)   38.0 (12.90)   16.9 (6.68)  26.74 (4.71)
DMN + HQT 58. 23 (0.80)   66.12 (5.58)   94.19 (6.35) 40.8 (10.47)   19.0 (2.36) 28.89 (2.20) 
DMN + YGJ 66.77 (5.29) 75.09 (2.25) 79.37 (3.39)   47.0 (21.02) 20.0 (15.19) 26.13 (3.67)
DMN + XCHT 68.41 (5.82) 77.42 (5.59) 93.38 (1.98) 55.3 (14.34) 23.0 (13.52) 25.88 (2.95)
 P < 0.05   P < 0.01 (vs DMN+ water)






Results are expressed as mean (SD).
Table 2: Effects of five Chinese medicine decoctions on liver hydroxyproline (Hyp) content in DMN-induced liver fibrosis of rats
Group Group size (n) Hyp content μg/g mean (SD) Fibrotic grade* 95% CI of U**
01 2 3 4
Control 10 179.36(9.90)   1 0 0000( - 0 . 1 1 0  t o  0 . 2 2 8 )   
2-week DMN 6 289.06 (26.95)   0 0 4 2 0 (0.051 to 0.486)  
DMN + water 12 641.71 (54.22) 0 0 0 3 9 (0.586 to 0.894)
DMN + YCHT 12 434.16 (25.39)  0 0 5 6 1 (0.226 to 0.548) 
DMN + XYXT 12 586.91 (37.53) 0 0 0 5 7 (0.522 to 0.829)
DMN + HQT 12 559.04 (47.06) 0 0 0 8 4 (0.580 to 0.734)
DMN + YGJ 12 647.17 (64.73) 0 0 1 6 5 (0.435 to 0.743)
DMN + XCHT 10 636.35 (48.53) 0 0 1 7 2 (0.333 to 0.671)
*: grade 0: normal; grade 1: very slight; grade 2: slight; grade 3: moderate; grade 4: severe. Data are expressed as numbers of animals with each 
fibrotic grade.
**: 95% confidence interval of the U values obtained from ridit analysis
 P < 0.05   P < 0.01 (vs DMN+ water)
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(a) Real-time quantitative PCRIn the 2-week DMN group, α-SMA mRNA expression level increased (vs control rats, P < 0.01) Figure 2
(a) Real-time quantitative PCR. In the 2-week DMN group, α-SMA mRNA expression level increased (vs control rats, P < 
0.01). In the DMN + water group, α-SMA mRNA expression level also increased (vs control rats, P < 0.01). In the DMN + 
YCHT group, α-SMA mRNA expression level decreased (vs DMN + water rats, P < 0.05).  P < 0.05    P < 0.01 (vs DMN+ water) 
 P < 0.05  P < 0.01 (vs 2-week DMN). (b) Western blot. Western blot analysis of total protein extracts was performed 
with antibodies recognizing α-SMA and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). YCHT reduced α-SMA protein 
expression significantly (vs DMN + water). (c) Immunohistochemical analysis ×200. (A) In the control group, α-SMA-positive 
HSCs were weakly stained and only detected in vascular structures. (B) and (C) With DMN-intoxication, number of α-SMA-
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and infiltration were significantly reduced. Liver fibrous
tissue hyperplasia and liver structural alterations were
markedly inhibited. Only one of the 12 rats had liver cir-
rhosis, cirrhosis formation rate being 8.3%. Hyp content
was 44.9%, lower than that of the DMN + water group.
The other four decoctions did not show these significant
effects. Hepatocyte necrosis, sinusoidal endothelial
injury, inflammation and bleeding induced by DMN were
considered to be the major factors for the development of
liver fibrosis. Sustained inflammation caused extracellular
matrix deposition and nodular regenerative transition
[16,28].
Activation of HSCs is a key factor in developing liver fibro-
sis. Inhibition of the accumulation of activated HSCs by
modulating either their activation and/or proliferation or
promoting their apoptosis is thus an important therapeu-
tic strategy. YCHT reduced α-SMA (a marker of activated
HSCs [29]) expression at mRNA and protein synthesis lev-
els. Our results indicated that the molecular mechanism
of anti-fibrotic effects by YCHT might be due to the sup-
pression of HSCs' activation.
In another study by our team, we used the same decoc-
tions for treating liver cirrhosis induced by DMN in rats at
the cirrhosis formation stage. The rats were injected with
DMN for four weeks and were treated with the herbal
medicines for two weeks. Among the five decoctions, both
YCHT and HQT exerted significant therapeutic effects and
YCHT  was overall more effective than HQT  [29]. The
present study demonstrated the effectiveness of YCHT in
DMN-induced rat liver fibrosis/cirrhosis and pathological
changes in different stages of the disease. In this study, rats
were exposed to DMN and received herbal medicine inter-
vention after the formation of liver fibrosis after two
weeks of DMN-intoxication. In general no significant
effect of intervention by HQT was found; although it was
previously found to be effective in DMN-induced liver cir-
rhosis. It is probable that the rats which were exposed to
DMN sustained as long as intervention therapy was given.
However, when liver cirrhosis was formed and pathogenic
factors were removed for two weeks, inflammatory injury
could be relaxed gradually. Hepatic parenchymal cell
injury appears gradually in this period. Thus, pathological
changes in various stages of liver fibrosis and cirrhosis
may affect the efficacy of the decoctions.
Conclusion
Among the five Chinese medicine decoctions, YCHT dem-
onstrated the most significant anti-fibrotic effects on
DMN-induced liver cirrhosis/fibrosis in rats, which may
be a result of the decoction's inhibitory effects on HSCs'
activation.
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